Belgium· BE-AMP-SAM303484-00

Cervarix

A humaner papillomvirus (typen 16, 18) product containing human papillomavirus, types 16,18, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 10 of our 19 countries.

ATC J07BM02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCervarixATCJ07BM02REGISTER NO.BE-AMP-SAM303484-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Humaner papillomvirus (typen 16, 18) is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BM02 (humaner papillomvirus (typen 16, 18)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Humaner papillomvirus (typen 16, 18) · ATC J07BM02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Papillomavirus, Types 16,18
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BM02
ATC class
Humaner Papillomvirus (Typen 16, 18)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

1 priced
  • be_apb
    2385136
    EUR 71.05
  • be_apb
    0788547
  • be_apb
    7707573
  • be_apb
    3147410

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/857cb6b6-d181-4c5f-98f0-d5d7123d2068
GET /v1/drugs/857cb6b6-d181-4c5f-98f0-d5d7123d2068?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cervarix",
  "name_fr": "Cervarix",
  "name_nl": "Cervarix",
  "amp_code": "SAM303484-00",
  "strengths": null,
  "pack_count": 8,
  "substances": [
    "Human Papillomavirus, Types 16,18"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Papillomavirus (human types 16, 18)",
  "authorisation_numbers": [
    "EU/1/07/419/004",
    "EU/1/07/419/005",
    "EU/1/07/419/006",
    "EU/1/07/419/007",
    "EU/1/07/419/008",
    "EU/1/07/419/009"
  ]
}

See everything about humaner papillomvirus (typen 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.